Escalon® Medical Corp. Enters Agreement to Distribute Diaton Tonometer

    Escalon® Medical Corp. Enters Agreement to Distribute Diaton Tonometer

The Diaton Tonometer joins Sonomed Escalon's VuPad™ at ASCRS Booth 873

PR Newswire

ARDMORE, Pa., April 25, 2014

ARDMORE, Pa., April 25, 2014 /PRNewswire/ -- Escalon Medical Corp. (Nasdaq:
ESMC) today announced that it has entered into a distribution agreement with
Long Beach, NY based BiCOM Inc., to distribute its transpalpebral "Diaton"
tonometer. The Diaton tonometer will be featured alongside the Company's new
VuPad™ ultrasound system at the Annual Symposium and Congress of the American
Society of Cataract and Refractive Surgery (ASCRS) in Boston, April 25-29
(booth 873).

"We are excited to offer the Diaton tonometer as a complementary product to
our pachymetry ultrasound products," commented Chief Executive Officer,
Richard J. DePiano Jr. "Through our experienced sales organization with reach
into 90 countries, we are well positioned to expand distribution of the Diaton
tonometer, particularly into Asia and Europe.Adding best-in-class ophthalmic
product solutions to our distribution network also demonstrates our ongoing
commitment to build on our position as a leader in ophthalmic diagnostic

The Diaton tonometer is the world's only non-corneal contact tonometer used
through the eyelid to quickly and painlessly determine intraocular pressure
without directly touching the cornea or requiring use of topical anesthesia.
The Diaton tonometer is particularly useful in cases where standard direct
applanation tonometry is difficult or not viable, such as with pediatric
patients, in presence of certain corneal pathology, following corneal surgery,
and in cases of eye trauma.

The Sonomed Escalon booth 873 at ASCRS will also feature for sale the
Company's newly introduced VuPad™ portable ultrasound device. The VuPad™ had a
successful showing at the recent 2014 World Ophthalmic Congress in Tokyo as
well as The Exchange 2014 in Boston, the annual meeting of Vision Source,
North America's premier network of private practice optometrists.

About Escalon Medical
Founded in 1987, Escalon Medical Corp. (NASDAQ: ESMC)  specializes in the
development, marketing and distribution of ophthalmic diagnostic imaging and
surgical products branded under the Sonomed Escalon name. Products include a
variety of ophthalmic ultrasound, digital imaging and photography, and image
management systems, as well as surgical products including intraocular gases,
fiber optic light guides and sources, and other surgical vitreoretinal
instruments. The Company seeks to grow its ophthalmic business by further
developing and diversifying its product offering through internal development
programs, strategic partnerships, and the acquisition of technology so as to
best leverage the Company's distribution capabilities. The Company has
headquarters in Ardmore, Pennsylvania and research and development,
manufacturing and distribution operations in Lake Success, New York, New
Berlin, Wisconsin and Stoneham, Massachusetts. For additional information
visit and

Forward Looking Statements
This press release contains statements that are considered forward-looking
under the Private Securities Litigation Reform Act of 1995, including
statements about the Company's future prospects. These statements are based on
the Company's current expectations and are subject to a number of
uncertainties and risks, and actual results may differ materially. The
uncertainties and risks include whether the Company is able to: implement its
growth and marketing strategies, improve upon its operations, including, the
ability to make acquisitions and the integration of any acquisitions it may
undertake, if any, of which there can be no assurance; grow our remaining
ophthalmic business unit, including expanding its product pipeline, obtaining
regulatory and marketing approvals, and commercializing, manufacturing and
shipping new products; improve our financial position; implement cost
reductions; generate cash; and identify, finance and enter into business
relationships and acquisitions. Other factors include uncertainties and risks
related to: new product development, regulatory and marketing approvals,
commercialization, manufacturing and market acceptance of new products;
marketing acceptance of existing products in new markets; research and
development activities, including failure to demonstrate clinical efficacy;
delays by regulatory authorities, scientific and technical advances by the
Company or third parties; introduction of competitive products; ability to
reduce staffing and other costs and retain benefit of prior reductions; third
party reimbursement and physician training, and general economic conditions.
Further information about these and other relevant risks and uncertainties may
be found in the Company's report on Form 10- K for year ended June 30, 2013,
and its other filings with the Securities and Exchange Commission, all of
which are available from the Securities and Exchange Commission as well as
other sources.

SOURCE Escalon Medical Corp.

Contact: Richard J. DePiano, Jr, President and CEO, 610-688-6830; Alison
Ziegler, Cameron Associates, 212-554-5469
Press spacebar to pause and continue. Press esc to stop.